About | Free Trial

Last Update

2016-07-10T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Gary Woodnutt?

Dr. Gary Woodnutt

Senior Vice President, Research and Development

Verenium Corporation

Direct Phone: (858) ***-****       

Verenium Corporation

Find other employees at this company (128)

Background Information

Employment History

Senior Vice President of Research

Lpath , Inc.

Vice President, Open Innovation

Pfizer Inc

Position, Pharmaceutical Industry

GlaxoSmithKline plc

Affiliations

Speakers and Advisor
IBC USA Conferences , Inc.

Parent Member
Del Mar Union School District

Education

B.S. degree
Biochemistry and Physiology
University of Leeds

Bachelors degree
Biochemistry and Physiology
Leeds University

Ph.D

Ph.D degree
Biochemistry and Physiology
University of Reading

PhD

Reading University

Web References (55 Total References)


Gary Woodnutt ...

phx.corporate-ir.net [cached]

Gary Woodnutt Ph.D.

Senior Vice President and Chief Scientific Officer
Dr. Woodnutt joined Lpath in April 2013. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at CovX, a division of Pfizer acquired in 2007, from 2012 to 2013, and as Vice President of Biology Research from 2006 to 2012. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Gary Woodnutt ...

phx.corporate-ir.net [cached]

Gary Woodnutt Ph.D.

...
Gary Woodnutt Ph.D.
Senior Vice President and Chief Scientific Officer
Dr. Woodnutt joined Lpath in April 2013. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at CovX, a division of Pfizer acquired in 2007, from 2012 to 2013, and as Vice President of Biology Research from 2006 to 2012. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Gary Woodnutt, ...

www.sec.gov [cached]

Gary Woodnutt, Ph.D.

...
Gary Woodnutt Ph.D.
Senior Vice President and Chief Scientific Officer
Dr. Woodnutt joined Lpath in April 2013. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at CovX, a division of Pfizer acquired in 2007, from 2012 to 2013, and as Vice President of Biology Research from 2006 to 2012. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Executive Team | The Lpath Team | Lpath Incorporated

www.lpath.com [cached]

Gary Woodnutt, Ph.D. - Sr. Vice President & Chief Scientific Officer

Background: Dr. Woodnutt brings to Lpath extensive experience in drug discovery and pharmaceutical research. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at Pfizer/CovX, but his primary role at CovX, from 2006 to 2012, was as Vice President of Biology Research. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


CovX: company > management

www.covx.com [cached]

Gary Woodnutt, PhD

...
Gary Woodnutt, PhD , joined CovX in March, 2006 as head of biology and brings more than 25 years of experience in the pharmaceutical industry. Before joining CovX, Dr. Woodnutt was head of pharmaceutical research and development at Diversa where he oversaw all efforts related to the optimization of therapeutic proteins and small molecule discovery. Prior to Diversa, he was at GlaxoSmithKline where he was vice president of biology, microbial, musculoskeletal and proliferative disease CEDD and responsible for discovery and non-clinical development and market support activities in the anti-infective and host defense areas. During his time with GlaxoSmithKline, Dr. Woodnutt contributed to multiple IND and NDA filings for anti-infective drugs. He is on the editorial board of Antimicrobial Agents and Chemotherapy and is a section editor for Drug Discovery Today: Therapeutic Strategies and Current Opinion in Biotechnology. He received his Bachelors degree in Biochemistry and Physiology from Leeds University, UK and his PhD from Reading University, UK.

Similar Profiles

Other People with this Name

Other people with the name Woodnutt

Melody Woodnutt
ACA Community Artist

Tess Woodnutt
Alderney Sailing Club

Andy Woodnutt
Sophos Plc

Tom Woodnutt
Good Measures Limited

Samantha Woodnutt
Icon Moving Services LTD

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory